These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32307223)

  • 21. Can China's COVID-19 strategy work elsewhere?
    Kupferschmidt K; Cohen J
    Science; 2020 Mar; 367(6482):1061-1062. PubMed ID: 32139521
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19 Epidemic: Possibility of Artificial Intelligence in Infection Control and Prevention.
    Qi ZY; Zhao PY; Geng SH; Yi HM; Yang LP
    J Epidemiol; 2020 Aug; 30(8):371. PubMed ID: 32507776
    [No Abstract]   [Full Text] [Related]  

  • 23. Non-pharmaceutical intervention strategies for outbreak of COVID-19 in Hangzhou, China.
    Kong Q; Jin H; Sun Z; Kao Q; Chen J
    Public Health; 2020 May; 182():185-186. PubMed ID: 32339883
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention and management of COVID-19 in hemodialysis centers.
    Tang Y; Xin Y; Deng F
    Am J Manag Care; 2020 Aug; 26(8):e237-e238. PubMed ID: 32835464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication-assisted treatment of opiate dependence is gaining favor.
    Jerry JM; Collins GB
    Cleve Clin J Med; 2013 Jun; 80(6):345-9. PubMed ID: 23733899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review.
    Notley C; Blyth A; Maskrey V; Craig J; Holland R
    Eur Addict Res; 2013; 19(6):287-98. PubMed ID: 23652159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [COVID-19 pandemic: global epidemiological trends and China's subsequent preparedness and responses].
    Guo Y; Huang YM; Huang J; Jin YZ; Jiang W; Liu PL; Liu FJ; Ma JX; Ma JY; Wang Y; Xie Z; Yin H; Zhao CS; Zhou SD; Zhang J; Zheng ZJ;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):642-647. PubMed ID: 32164401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telemedicine's Role in Addressing the Opioid Epidemic.
    Yang YT; Weintraub E; Haffajee RL
    Mayo Clin Proc; 2018 Sep; 93(9):1177-1180. PubMed ID: 30097301
    [No Abstract]   [Full Text] [Related]  

  • 29. Combating the COVID-19 Epidemic: Experiences from Vietnam.
    Ha BTT; Ngoc Quang L; Mirzoev T; Tai NT; Thai PQ; Dinh PC
    Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32365851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone maintenance-lessons from two systems in China.
    Lee SS; Newman R
    Harm Reduct J; 2017 Sep; 14(1):66. PubMed ID: 28946906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 pandemic: perspectives on an unfolding crisis.
    Spinelli A; Pellino G
    Br J Surg; 2020 Jun; 107(7):785-787. PubMed ID: 32191340
    [No Abstract]   [Full Text] [Related]  

  • 32. Addressing COVID-19 in Afghanistan: What are the efforts and challenges?
    Lucero-Prisno DE; Ahmadi A; Essar MY; Lin X; Adebisi YA
    J Glob Health; 2020 Dec; 10(2):020341. PubMed ID: 33110541
    [No Abstract]   [Full Text] [Related]  

  • 33. Dermatology staff participate in fight against Covid-19 in China.
    Zheng Y; Lai W
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):e210-e211. PubMed ID: 32201983
    [No Abstract]   [Full Text] [Related]  

  • 34. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.
    Phelan AL; Katz R; Gostin LO
    JAMA; 2020 Feb; 323(8):709-710. PubMed ID: 31999307
    [No Abstract]   [Full Text] [Related]  

  • 35. As normalcy returns, can China keep COVID-19 at bay?
    Normile D
    Science; 2020 Apr; 368(6486):18-19. PubMed ID: 32241931
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonpharmaceutical interventions for tackling the COVID-19 epidemic in Brazil.
    Garcia LP; Duarte E
    Epidemiol Serv Saude; 2020 Apr; 29(2):e2020222. PubMed ID: 32294756
    [No Abstract]   [Full Text] [Related]  

  • 37. Department of rehabilitation medicine in Shanghai response for coronavirus disease 2019: the impact and challenges.
    Zhong Z; Zhang J; Chen J; Liu B
    Eur J Phys Rehabil Med; 2020 Jun; 56(3):345-346. PubMed ID: 32293815
    [No Abstract]   [Full Text] [Related]  

  • 38. Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City.
    Burzynski J; Macaraig M; Nilsen D; Schluger NW
    Int J Tuberc Lung Dis; 2020 Jul; 24(7):735-736. PubMed ID: 32718411
    [No Abstract]   [Full Text] [Related]  

  • 39. Outpatient Teledermatology Implementation During the COVID-19 Pandemic: Challenges and Lessons Learned.
    Farshchian M; Potts G; Kimyai-Asadi A; Mehregan D; Daveluy S
    J Drugs Dermatol; 2020 Jun; 19(6):683. PubMed ID: 32574014
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel coronavirus pneumonia emergency in Zhuhai: impact and challenges.
    Jin H; Liu J; Cui M; Lu L
    J Hosp Infect; 2020 Apr; 104(4):452-453. PubMed ID: 32068012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.